Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News > 2018

Pharma News, 2018

Patient death prompts FDA hold on Mersana’s lead cancer ADC
Patient death prompts FDA hold on Mersana’s lead cancer ADC
Another antibody-drug conjugate has been stalled by concerns over safety.
Swiss, German drugmakers join U.S. price freeze
Swiss, German drugmakers join U.S. price freeze
ZURICH (Reuters) - European drugmakers Roche, Bayer and Merck KGaA became the latest companies to freeze prices in the United States for the rest of 2018 following criticism by President Donal...
Apollo to buy LifePoint in latest private equity bet on healthcare
Apollo to buy LifePoint in latest private equity bet on healthcare
(Reuters) - Apollo Global Management will buy LifePoint Health in a $5.
FDA approves first targeted treatment for patients with relapsed or refractory acute myeloid leukemia who have a certain genetic mutation
FDA approves first targeted treatment for patients with relapsed or refractory acute myeloid leukemia who have a certain genetic mutation
The U.
Pfizer-Lilly pain drug meets late-stage trial goals
Pfizer-Lilly pain drug meets late-stage trial goals
An experimental osteoarthritis drug developed by Pfizer Inc and Eli Lilly and Co achieved its main goal of lowering pain in a late stage trial, the companies said on Wednesday, potentially offering a ...
Merck lowers prices of some drugs after Trump calls out industry
Merck lowers prices of some drugs after Trump calls out industry
(Reuters) - Merck & Co on Thursday announced price cuts to some of its medicines, including a 60 percent reduction to a hepatitis C treatment, after U.
Selective neuronal silencing using synthetic botulinum molecules alleviates chronic pain in mice
Selective neuronal silencing using synthetic botulinum molecules alleviates chronic pain in mice
Chronic pain affects more than 25 million Americans and is associated with reduced life span, anxiety, and depression.
Astellas Is Considering Selling Europe Assets to Raise Cash
Astellas Is Considering Selling Europe Assets to Raise Cash
Astellas Pharma Inc.
China Focus: China's new Alzheimer's drug completes phase 3 clinical trial
China Focus: China's new Alzheimer's drug completes phase 3 clinical trial
SHANGHAI, July 17 (Xinhua) -- A Chinese research group on Tuesday announced progress in developing a drug to treat Alzheimer's disease.
Common type 2 diabetes drug could be mixed with vitamin B to stop medication causing nausea and vomiting, finds study
Common type 2 diabetes drug could be mixed with vitamin B to stop medication causing nausea and vomiting, finds study
Type 2 diabetes drugs could be modified with vitamins to stop them causing nausea and vomiting and improving the quality of life for millions of patients, a study claims.
AstraZeneca to stockpile drugs as Brexit 'safety net'
AstraZeneca to stockpile drugs as Brexit 'safety net'
AstraZeneca is increasing stockpiles of those medicines in Britain and Europe that could be affected by Brexit by around 20 percent, in preparation for potential disruption if the UK crashes out of th...
IBM extends deal using Watson to support veterans with cancer
IBM extends deal using Watson to support veterans with cancer
IBM is making further use of Watson in the fight against cancer.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand